Vaccine advisers to the USFDA voted Thursday to recommend the agency grant emergency use authorization to Pfizer’s coronavirus vaccine. 17 members of the Vaccines and Related Biological Products Advisory Committee voted yes, four voted no and one abstained. The FDA is now to decide whether to accept the recommendation.